Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland

Background: Challenges in post-marketing adverse event reporting are generally recognized. To enhance reporting, the concept of additional monitoring was introduced in 2012. Additional monitoring aims to enhance reporting of adverse events (AE) for medicines for which the clinical evidence base is l...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Andreas Sandberg, Pauliina Ehlers, Saku Torvinen, Heli Sandberg, Mia Sivén
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	additional monitoring black triangle adverse event reporting pharmacovigilance Medicine R
Acceso en línea:	https://doaj.org/article/b70d43ce107a4bfaad0e36f9b0ba96da
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b70d43ce107a4bfaad0e36f9b0ba96da
record_format	dspace
spelling	oai:doaj.org-article:b70d43ce107a4bfaad0e36f9b0ba96da2021-11-25T17:45:54ZRegulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland10.3390/healthcare91115402227-9032https://doaj.org/article/b70d43ce107a4bfaad0e36f9b0ba96da2021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9032/9/11/1540https://doaj.org/toc/2227-9032Background: Challenges in post-marketing adverse event reporting are generally recognized. To enhance reporting, the concept of additional monitoring was introduced in 2012. Additional monitoring aims to enhance reporting of adverse events (AE) for medicines for which the clinical evidence base is less well developed. Purpose: The purpose was to get a deeper understanding of the underlying reasons why additional monitoring has not increased AE reporting as much as initially hoped. We examined how healthcare professionals (HCPs) in Finland perceive additional monitoring, why they do or do not report AEs more readily for these medicines and how they interact with patients treated with additionally monitored medicines. Methods: An anonymous, open questionnaire was developed and made available online at the e-form portal of University of Helsinki. Physicians, nurses, and pharmacists were invited to complete the questionnaire via their respective trade or area unions. Content analysis of answers to open-ended questions was performed by two independent coders. Results: Pharmacists have the best understanding about additional monitoring but at the same time do not recognize their role in enhancing monitoring. Only 40% of HCPs working with patients knows always or often if a specific medicine is additionally monitored. Half (53%) of HCPs do not tell or tell only rarely patients about additional monitoring. 18% of HCPs reported having received additional monitoring training whereas 29% had received general AE reporting training. AE reporting was more common among HCPs who had received training. Conclusions: Additional monitoring awareness among HCPs and patients should be increased by organizing regular educational events and making additional monitoring more visible. Educational events should emphasize the significance additional monitoring has on patient safety and promote a reporting culture among HCPs.Andreas SandbergPauliina EhlersSaku TorvinenHeli SandbergMia SivénMDPI AGarticleadditional monitoringblack triangleadverse event reportingpharmacovigilanceMedicineRENHealthcare, Vol 9, Iss 1540, p 1540 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	additional monitoring black triangle adverse event reporting pharmacovigilance Medicine R
spellingShingle	additional monitoring black triangle adverse event reporting pharmacovigilance Medicine R Andreas Sandberg Pauliina Ehlers Saku Torvinen Heli Sandberg Mia Sivén Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland
description	Background: Challenges in post-marketing adverse event reporting are generally recognized. To enhance reporting, the concept of additional monitoring was introduced in 2012. Additional monitoring aims to enhance reporting of adverse events (AE) for medicines for which the clinical evidence base is less well developed. Purpose: The purpose was to get a deeper understanding of the underlying reasons why additional monitoring has not increased AE reporting as much as initially hoped. We examined how healthcare professionals (HCPs) in Finland perceive additional monitoring, why they do or do not report AEs more readily for these medicines and how they interact with patients treated with additionally monitored medicines. Methods: An anonymous, open questionnaire was developed and made available online at the e-form portal of University of Helsinki. Physicians, nurses, and pharmacists were invited to complete the questionnaire via their respective trade or area unions. Content analysis of answers to open-ended questions was performed by two independent coders. Results: Pharmacists have the best understanding about additional monitoring but at the same time do not recognize their role in enhancing monitoring. Only 40% of HCPs working with patients knows always or often if a specific medicine is additionally monitored. Half (53%) of HCPs do not tell or tell only rarely patients about additional monitoring. 18% of HCPs reported having received additional monitoring training whereas 29% had received general AE reporting training. AE reporting was more common among HCPs who had received training. Conclusions: Additional monitoring awareness among HCPs and patients should be increased by organizing regular educational events and making additional monitoring more visible. Educational events should emphasize the significance additional monitoring has on patient safety and promote a reporting culture among HCPs.
format	article
author	Andreas Sandberg Pauliina Ehlers Saku Torvinen Heli Sandberg Mia Sivén
author_facet	Andreas Sandberg Pauliina Ehlers Saku Torvinen Heli Sandberg Mia Sivén
author_sort	Andreas Sandberg
title	Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland
title_short	Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland
title_full	Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland
title_fullStr	Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland
title_full_unstemmed	Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland
title_sort	regulation awareness and experience of additional monitoring among healthcare professionals in finland
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/b70d43ce107a4bfaad0e36f9b0ba96da
work_keys_str_mv	AT andreassandberg regulationawarenessandexperienceofadditionalmonitoringamonghealthcareprofessionalsinfinland AT pauliinaehlers regulationawarenessandexperienceofadditionalmonitoringamonghealthcareprofessionalsinfinland AT sakutorvinen regulationawarenessandexperienceofadditionalmonitoringamonghealthcareprofessionalsinfinland AT helisandberg regulationawarenessandexperienceofadditionalmonitoringamonghealthcareprofessionalsinfinland AT miasiven regulationawarenessandexperienceofadditionalmonitoringamonghealthcareprofessionalsinfinland
_version_	1718412068639473664

Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland

Ejemplares similares